Irsko - angličtina - HPRA (Health Products Regulatory Authority)

guerbet - ioversol - solution for injection - 240 mg i/ millilitre(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; ioversol

Malajsie - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - satralizumab -

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 40 mg - suspension, powder for - excipient ingredients: xanthan gum; citric acid monohydrate; sucrose; titanium dioxide; sodium benzoate; sodium citrate dihydrate; colloidal anhydrous silica; flavour - voriconazole pfs is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 40 mg - suspension, powder for - excipient ingredients: sodium citrate dihydrate; citric acid monohydrate; xanthan gum; sucrose; titanium dioxide; sodium benzoate; colloidal anhydrous silica; flavour - voriconazole pfs genpar is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 40 mg - suspension, powder for - excipient ingredients: sodium benzoate; sodium citrate dihydrate; sucrose; citric acid monohydrate; colloidal anhydrous silica; titanium dioxide; xanthan gum; flavour - vzole pfs is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 40 mg - suspension, powder for - excipient ingredients: xanthan gum; sucrose; citric acid monohydrate; sodium benzoate; colloidal anhydrous silica; sodium citrate dihydrate; titanium dioxide; flavour - vorizole pfs is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 40 mg - suspension, powder for - excipient ingredients: citric acid monohydrate; sodium benzoate; sodium citrate dihydrate; sucrose; titanium dioxide; colloidal anhydrous silica; xanthan gum; flavour - zolens pfs is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - voriconazole, quantity: 40 mg - suspension, powder for - excipient ingredients: citric acid monohydrate; titanium dioxide; sodium citrate dihydrate; xanthan gum; sodium benzoate; colloidal anhydrous silica; sucrose; flavour - voriconazole pfs gppl is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including oesophageal and systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Spojené arabské emiráty - angličtina - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

metropolitan medical marketing sole proprietorship llc united kingdom - 1 prefilled syringe (10 ml) - injection - 1.8mg/10 ml pfs - cardiovascular system-sympathomimetics, respiratory system-antihistamines, hyposensitisation , allergic e

Keňa - angličtina - Pharmacy and Poisons Board

enoxaparin sodium - solution for injection in pre-filled syringe - 100mg / pfs - enoxaparin